ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy

Study limitation reported by the research below: “This is a single case report (n=1) published as a letter in NEJM; the 'practice changing' flag reflects novelty and potential signal strength, but clinical adoption should await larger prospective studies.”

Papers